Global Nirsevimab Market Growth 2026-2032
The global Nirsevimab market size is predicted to grow from US$ 2886 million in 2025 to US$ 9920 million in 2032; it is expected to grow at a CAGR of 19.4% from 2026 to 2032.
In 2025, global Nirsevimab production reached approximately 12 million units.Nirsevimab is a long-acting human immunoglobulin G1 kappa monoclonal antibody targeting the fusion protein of respiratory syncytial virus. It is designed to provide direct and rapid passive immune protection by binding to the prefusion conformation of the RSV F protein, thereby inhibiting viral fusion with host cell membranes and preventing subsequent infection. Approved for use in neonates and infants during their first RSV season, it offers a convenient single-dose administration and an extended half-life to sustain protection throughout the high-risk period, representing an important preventive option for respiratory syncytial virus infection in the pediatric population
Nirsevimab has established a dominant and rapidly expanding position in the global RSV prophylactic market, driven by its transformative clinical profile and unmet medical need. As a long-acting, single-dose monoclonal antibody, it addresses critical limitations of previous therapies by providing immediate, sustained protection for infants through an entire RSV season, fundamentally shifting clinical practice and public health strategies. Its market penetration is fueled by widespread regulatory approvals, formal inclusion in national pediatric immunization guidelines across major markets, and strong real-world evidence demonstrating significant reductions in infant hospitalizations. Despite intensifying competition from emerging RSV antibodies and maternal vaccines, nirsevimab maintains a leading edge through established brand recognition, optimized global supply chains, and expanded geographic reach into high-potential emerging markets. The market landscape continues to evolve with ongoing efforts to balance supply with surging global demand, adapt to evolving clinical recommendations, and navigate pricing and access dynamics across diverse healthcare systems, solidifying its role as a cornerstone in pediatric RSV prevention.
LP Information, Inc. (LPI) ' newest research report, the ?Nirsevimab Industry Forecast? looks at past sales and reviews total world Nirsevimab sales in 2025, providing a comprehensive analysis by region and market sector of projected Nirsevimab sales for 2026 through 2032. With Nirsevimab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nirsevimab industry.
This Insight Report provides a comprehensive analysis of the global Nirsevimab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nirsevimab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nirsevimab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nirsevimab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nirsevimab.
This report presents a comprehensive overview, market shares, and growth opportunities of Nirsevimab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Nirsevimab market?
What factors are driving Nirsevimab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nirsevimab market opportunities vary by end market size?
How does Nirsevimab break out by Type, by Application?
In 2025, global Nirsevimab production reached approximately 12 million units.Nirsevimab is a long-acting human immunoglobulin G1 kappa monoclonal antibody targeting the fusion protein of respiratory syncytial virus. It is designed to provide direct and rapid passive immune protection by binding to the prefusion conformation of the RSV F protein, thereby inhibiting viral fusion with host cell membranes and preventing subsequent infection. Approved for use in neonates and infants during their first RSV season, it offers a convenient single-dose administration and an extended half-life to sustain protection throughout the high-risk period, representing an important preventive option for respiratory syncytial virus infection in the pediatric population
Nirsevimab has established a dominant and rapidly expanding position in the global RSV prophylactic market, driven by its transformative clinical profile and unmet medical need. As a long-acting, single-dose monoclonal antibody, it addresses critical limitations of previous therapies by providing immediate, sustained protection for infants through an entire RSV season, fundamentally shifting clinical practice and public health strategies. Its market penetration is fueled by widespread regulatory approvals, formal inclusion in national pediatric immunization guidelines across major markets, and strong real-world evidence demonstrating significant reductions in infant hospitalizations. Despite intensifying competition from emerging RSV antibodies and maternal vaccines, nirsevimab maintains a leading edge through established brand recognition, optimized global supply chains, and expanded geographic reach into high-potential emerging markets. The market landscape continues to evolve with ongoing efforts to balance supply with surging global demand, adapt to evolving clinical recommendations, and navigate pricing and access dynamics across diverse healthcare systems, solidifying its role as a cornerstone in pediatric RSV prevention.
LP Information, Inc. (LPI) ' newest research report, the ?Nirsevimab Industry Forecast? looks at past sales and reviews total world Nirsevimab sales in 2025, providing a comprehensive analysis by region and market sector of projected Nirsevimab sales for 2026 through 2032. With Nirsevimab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nirsevimab industry.
This Insight Report provides a comprehensive analysis of the global Nirsevimab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nirsevimab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nirsevimab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nirsevimab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nirsevimab.
This report presents a comprehensive overview, market shares, and growth opportunities of Nirsevimab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 50 mg (0.5 mL) / syringe
- 100 mg (1.0 mL) / syringe
- Hospital
- Retail
- Online
- Intramuscular Injection
- Subcutaneous Injection
- Prevention Of Respiratory Syncytial Virus Infection
- Reduction Of Severe Lower Respiratory Tract Disease
- Protection Of Infants During Rsv Season
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- Sanofi
What is the 10-year outlook for the global Nirsevimab market?
What factors are driving Nirsevimab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nirsevimab market opportunities vary by end market size?
How does Nirsevimab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nirsevimab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nirsevimab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nirsevimab by Country/Region, 2021, 2025 & 2032
2.2 Nirsevimab Segment by Type
2.2.1 50 mg (0.5 mL) / syringe
2.2.2 100 mg (1.0 mL) / syringe
2.2.3 Nirsevimab Sales by Type
2.2.3.1 Global Nirsevimab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nirsevimab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nirsevimab Sale Price by Type (2021-2026)
2.3 Nirsevimab Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Nirsevimab Sales by Sales Channels
2.3.4.1 Global Nirsevimab Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Nirsevimab Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Nirsevimab Sale Price by Sales Channels (2021-2026)
2.4 Nirsevimab Segment by Route of Administration
2.4.1 Intramuscular Injection
2.4.2 Subcutaneous Injection
2.4.3 Nirsevimab Sales by Route of Administration
2.4.3.1 Global Nirsevimab Sales Market Share by Route of Administration (2021-2026)
2.4.3.2 Global Nirsevimab Revenue and Market Share by Route of Administration (2021-2026)
2.4.3.3 Global Nirsevimab Sale Price by Route of Administration (2021-2026)
2.5 Nirsevimab Segment by Application
2.5.1 Prevention Of Respiratory Syncytial Virus Infection
2.5.2 Reduction Of Severe Lower Respiratory Tract Disease
2.5.3 Protection Of Infants During Rsv Season
2.5.4 Others
2.5.5 Nirsevimab Sales by Application
2.5.5.1 Global Nirsevimab Sale Market Share by Application (2021-2026)
2.5.5.2 Global Nirsevimab Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Nirsevimab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nirsevimab Breakdown Data by Company
3.1.1 Global Nirsevimab Annual Sales by Company (2021-2026)
3.1.2 Global Nirsevimab Sales Market Share by Company (2021-2026)
3.2 Global Nirsevimab Annual Revenue by Company (2021-2026)
3.2.1 Global Nirsevimab Revenue by Company (2021-2026)
3.2.2 Global Nirsevimab Revenue Market Share by Company (2021-2026)
3.3 Global Nirsevimab Sale Price by Company
3.4 Key Manufacturers Nirsevimab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nirsevimab Product Location Distribution
3.4.2 Players Nirsevimab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NIRSEVIMAB BY GEOGRAPHIC REGION
4.1 World Historic Nirsevimab Market Size by Geographic Region (2021-2026)
4.1.1 Global Nirsevimab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nirsevimab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nirsevimab Market Size by Country/Region (2021-2026)
4.2.1 Global Nirsevimab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nirsevimab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nirsevimab Sales Growth
4.4 APAC Nirsevimab Sales Growth
4.5 Europe Nirsevimab Sales Growth
4.6 Middle East & Africa Nirsevimab Sales Growth
5 AMERICAS
5.1 Americas Nirsevimab Sales by Country
5.1.1 Americas Nirsevimab Sales by Country (2021-2026)
5.1.2 Americas Nirsevimab Revenue by Country (2021-2026)
5.2 Americas Nirsevimab Sales by Type (2021-2026)
5.3 Americas Nirsevimab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nirsevimab Sales by Region
6.1.1 APAC Nirsevimab Sales by Region (2021-2026)
6.1.2 APAC Nirsevimab Revenue by Region (2021-2026)
6.2 APAC Nirsevimab Sales by Type (2021-2026)
6.3 APAC Nirsevimab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nirsevimab by Country
7.1.1 Europe Nirsevimab Sales by Country (2021-2026)
7.1.2 Europe Nirsevimab Revenue by Country (2021-2026)
7.2 Europe Nirsevimab Sales by Type (2021-2026)
7.3 Europe Nirsevimab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nirsevimab by Country
8.1.1 Middle East & Africa Nirsevimab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nirsevimab Revenue by Country (2021-2026)
8.2 Middle East & Africa Nirsevimab Sales by Type (2021-2026)
8.3 Middle East & Africa Nirsevimab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nirsevimab
10.3 Manufacturing Process Analysis of Nirsevimab
10.4 Industry Chain Structure of Nirsevimab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nirsevimab Distributors
11.3 Nirsevimab Customer
12 WORLD FORECAST REVIEW FOR NIRSEVIMAB BY GEOGRAPHIC REGION
12.1 Global Nirsevimab Market Size Forecast by Region
12.1.1 Global Nirsevimab Forecast by Region (2027-2032)
12.1.2 Global Nirsevimab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nirsevimab Forecast by Type (2027-2032)
12.7 Global Nirsevimab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Nirsevimab Product Portfolios and Specifications
13.1.3 AstraZeneca Nirsevimab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Nirsevimab Product Portfolios and Specifications
13.2.3 Sanofi Nirsevimab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nirsevimab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Nirsevimab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Nirsevimab by Country/Region, 2021, 2025 & 2032
2.2 Nirsevimab Segment by Type
2.2.1 50 mg (0.5 mL) / syringe
2.2.2 100 mg (1.0 mL) / syringe
2.2.3 Nirsevimab Sales by Type
2.2.3.1 Global Nirsevimab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Nirsevimab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Nirsevimab Sale Price by Type (2021-2026)
2.3 Nirsevimab Segment by Sales Channels
2.3.1 Hospital
2.3.2 Retail
2.3.3 Online
2.3.4 Nirsevimab Sales by Sales Channels
2.3.4.1 Global Nirsevimab Sales Market Share by Sales Channels (2021-2026)
2.3.4.2 Global Nirsevimab Revenue and Market Share by Sales Channels (2021-2026)
2.3.4.3 Global Nirsevimab Sale Price by Sales Channels (2021-2026)
2.4 Nirsevimab Segment by Route of Administration
2.4.1 Intramuscular Injection
2.4.2 Subcutaneous Injection
2.4.3 Nirsevimab Sales by Route of Administration
2.4.3.1 Global Nirsevimab Sales Market Share by Route of Administration (2021-2026)
2.4.3.2 Global Nirsevimab Revenue and Market Share by Route of Administration (2021-2026)
2.4.3.3 Global Nirsevimab Sale Price by Route of Administration (2021-2026)
2.5 Nirsevimab Segment by Application
2.5.1 Prevention Of Respiratory Syncytial Virus Infection
2.5.2 Reduction Of Severe Lower Respiratory Tract Disease
2.5.3 Protection Of Infants During Rsv Season
2.5.4 Others
2.5.5 Nirsevimab Sales by Application
2.5.5.1 Global Nirsevimab Sale Market Share by Application (2021-2026)
2.5.5.2 Global Nirsevimab Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Nirsevimab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Nirsevimab Breakdown Data by Company
3.1.1 Global Nirsevimab Annual Sales by Company (2021-2026)
3.1.2 Global Nirsevimab Sales Market Share by Company (2021-2026)
3.2 Global Nirsevimab Annual Revenue by Company (2021-2026)
3.2.1 Global Nirsevimab Revenue by Company (2021-2026)
3.2.2 Global Nirsevimab Revenue Market Share by Company (2021-2026)
3.3 Global Nirsevimab Sale Price by Company
3.4 Key Manufacturers Nirsevimab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nirsevimab Product Location Distribution
3.4.2 Players Nirsevimab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NIRSEVIMAB BY GEOGRAPHIC REGION
4.1 World Historic Nirsevimab Market Size by Geographic Region (2021-2026)
4.1.1 Global Nirsevimab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Nirsevimab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Nirsevimab Market Size by Country/Region (2021-2026)
4.2.1 Global Nirsevimab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Nirsevimab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nirsevimab Sales Growth
4.4 APAC Nirsevimab Sales Growth
4.5 Europe Nirsevimab Sales Growth
4.6 Middle East & Africa Nirsevimab Sales Growth
5 AMERICAS
5.1 Americas Nirsevimab Sales by Country
5.1.1 Americas Nirsevimab Sales by Country (2021-2026)
5.1.2 Americas Nirsevimab Revenue by Country (2021-2026)
5.2 Americas Nirsevimab Sales by Type (2021-2026)
5.3 Americas Nirsevimab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nirsevimab Sales by Region
6.1.1 APAC Nirsevimab Sales by Region (2021-2026)
6.1.2 APAC Nirsevimab Revenue by Region (2021-2026)
6.2 APAC Nirsevimab Sales by Type (2021-2026)
6.3 APAC Nirsevimab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Nirsevimab by Country
7.1.1 Europe Nirsevimab Sales by Country (2021-2026)
7.1.2 Europe Nirsevimab Revenue by Country (2021-2026)
7.2 Europe Nirsevimab Sales by Type (2021-2026)
7.3 Europe Nirsevimab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nirsevimab by Country
8.1.1 Middle East & Africa Nirsevimab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Nirsevimab Revenue by Country (2021-2026)
8.2 Middle East & Africa Nirsevimab Sales by Type (2021-2026)
8.3 Middle East & Africa Nirsevimab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nirsevimab
10.3 Manufacturing Process Analysis of Nirsevimab
10.4 Industry Chain Structure of Nirsevimab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nirsevimab Distributors
11.3 Nirsevimab Customer
12 WORLD FORECAST REVIEW FOR NIRSEVIMAB BY GEOGRAPHIC REGION
12.1 Global Nirsevimab Market Size Forecast by Region
12.1.1 Global Nirsevimab Forecast by Region (2027-2032)
12.1.2 Global Nirsevimab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Nirsevimab Forecast by Type (2027-2032)
12.7 Global Nirsevimab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Nirsevimab Product Portfolios and Specifications
13.1.3 AstraZeneca Nirsevimab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Nirsevimab Product Portfolios and Specifications
13.2.3 Sanofi Nirsevimab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nirsevimab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nirsevimab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50 mg (0.5 mL) / syringe
Table 4. Major Players of 100 mg (1.0 mL) / syringe
Table 5. Global Nirsevimab Sales by Type (2021-2026) & (Units)
Table 6. Global Nirsevimab Sales Market Share by Type (2021-2026)
Table 7. Global Nirsevimab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nirsevimab Revenue Market Share by Type (2021-2026)
Table 9. Global Nirsevimab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Nirsevimab Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Nirsevimab Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Nirsevimab Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Nirsevimab Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Nirsevimab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players of Intramuscular Injection
Table 19. Major Players of Subcutaneous Injection
Table 20. Global Nirsevimab Sales by Route of Administration (2021-2026) & (Units)
Table 21. Global Nirsevimab Sales Market Share by Route of Administration (2021-2026)
Table 22. Global Nirsevimab Revenue by Route of Administration (2021-2026) & ($ million)
Table 23. Global Nirsevimab Revenue Market Share by Route of Administration (2021-2026)
Table 24. Global Nirsevimab Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 25. Global Nirsevimab Sale by Application (2021-2026) & (Units)
Table 26. Global Nirsevimab Sale Market Share by Application (2021-2026)
Table 27. Global Nirsevimab Revenue by Application (2021-2026) & ($ million)
Table 28. Global Nirsevimab Revenue Market Share by Application (2021-2026)
Table 29. Global Nirsevimab Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Nirsevimab Sales by Company (2021-2026) & (Units)
Table 31. Global Nirsevimab Sales Market Share by Company (2021-2026)
Table 32. Global Nirsevimab Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Nirsevimab Revenue Market Share by Company (2021-2026)
Table 34. Global Nirsevimab Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Nirsevimab Producing Area Distribution and Sales Area
Table 36. Players Nirsevimab Products Offered
Table 37. Nirsevimab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Nirsevimab Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Nirsevimab Sales Market Share Geographic Region (2021-2026)
Table 42. Global Nirsevimab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Nirsevimab Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Nirsevimab Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Nirsevimab Sales Market Share by Country/Region (2021-2026)
Table 46. Global Nirsevimab Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Nirsevimab Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Nirsevimab Sales by Country (2021-2026) & (Units)
Table 49. Americas Nirsevimab Sales Market Share by Country (2021-2026)
Table 50. Americas Nirsevimab Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Nirsevimab Sales by Type (2021-2026) & (Units)
Table 52. Americas Nirsevimab Sales by Application (2021-2026) & (Units)
Table 53. APAC Nirsevimab Sales by Region (2021-2026) & (Units)
Table 54. APAC Nirsevimab Sales Market Share by Region (2021-2026)
Table 55. APAC Nirsevimab Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Nirsevimab Sales by Type (2021-2026) & (Units)
Table 57. APAC Nirsevimab Sales by Application (2021-2026) & (Units)
Table 58. Europe Nirsevimab Sales by Country (2021-2026) & (Units)
Table 59. Europe Nirsevimab Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Nirsevimab Sales by Type (2021-2026) & (Units)
Table 61. Europe Nirsevimab Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Nirsevimab Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Nirsevimab Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Nirsevimab Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Nirsevimab Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Nirsevimab
Table 67. Key Market Challenges & Risks of Nirsevimab
Table 68. Key Industry Trends of Nirsevimab
Table 69. Nirsevimab Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Nirsevimab Distributors List
Table 72. Nirsevimab Customer List
Table 73. Global Nirsevimab Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Nirsevimab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Nirsevimab Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Nirsevimab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Nirsevimab Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Nirsevimab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Nirsevimab Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Nirsevimab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Nirsevimab Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Nirsevimab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Nirsevimab Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Nirsevimab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Nirsevimab Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Nirsevimab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. AstraZeneca Basic Information, Nirsevimab Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca Nirsevimab Product Portfolios and Specifications
Table 89. AstraZeneca Nirsevimab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Sanofi Basic Information, Nirsevimab Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Nirsevimab Product Portfolios and Specifications
Table 94. Sanofi Nirsevimab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
Table 1. Nirsevimab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Nirsevimab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 50 mg (0.5 mL) / syringe
Table 4. Major Players of 100 mg (1.0 mL) / syringe
Table 5. Global Nirsevimab Sales by Type (2021-2026) & (Units)
Table 6. Global Nirsevimab Sales Market Share by Type (2021-2026)
Table 7. Global Nirsevimab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Nirsevimab Revenue Market Share by Type (2021-2026)
Table 9. Global Nirsevimab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Hospital
Table 11. Major Players of Retail
Table 12. Major Players of Online
Table 13. Global Nirsevimab Sales by Sales Channels (2021-2026) & (Units)
Table 14. Global Nirsevimab Sales Market Share by Sales Channels (2021-2026)
Table 15. Global Nirsevimab Revenue by Sales Channels (2021-2026) & ($ million)
Table 16. Global Nirsevimab Revenue Market Share by Sales Channels (2021-2026)
Table 17. Global Nirsevimab Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 18. Major Players of Intramuscular Injection
Table 19. Major Players of Subcutaneous Injection
Table 20. Global Nirsevimab Sales by Route of Administration (2021-2026) & (Units)
Table 21. Global Nirsevimab Sales Market Share by Route of Administration (2021-2026)
Table 22. Global Nirsevimab Revenue by Route of Administration (2021-2026) & ($ million)
Table 23. Global Nirsevimab Revenue Market Share by Route of Administration (2021-2026)
Table 24. Global Nirsevimab Sale Price by Route of Administration (2021-2026) & (US$/Unit)
Table 25. Global Nirsevimab Sale by Application (2021-2026) & (Units)
Table 26. Global Nirsevimab Sale Market Share by Application (2021-2026)
Table 27. Global Nirsevimab Revenue by Application (2021-2026) & ($ million)
Table 28. Global Nirsevimab Revenue Market Share by Application (2021-2026)
Table 29. Global Nirsevimab Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Nirsevimab Sales by Company (2021-2026) & (Units)
Table 31. Global Nirsevimab Sales Market Share by Company (2021-2026)
Table 32. Global Nirsevimab Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Nirsevimab Revenue Market Share by Company (2021-2026)
Table 34. Global Nirsevimab Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Nirsevimab Producing Area Distribution and Sales Area
Table 36. Players Nirsevimab Products Offered
Table 37. Nirsevimab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Nirsevimab Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Nirsevimab Sales Market Share Geographic Region (2021-2026)
Table 42. Global Nirsevimab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Nirsevimab Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Nirsevimab Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Nirsevimab Sales Market Share by Country/Region (2021-2026)
Table 46. Global Nirsevimab Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Nirsevimab Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Nirsevimab Sales by Country (2021-2026) & (Units)
Table 49. Americas Nirsevimab Sales Market Share by Country (2021-2026)
Table 50. Americas Nirsevimab Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Nirsevimab Sales by Type (2021-2026) & (Units)
Table 52. Americas Nirsevimab Sales by Application (2021-2026) & (Units)
Table 53. APAC Nirsevimab Sales by Region (2021-2026) & (Units)
Table 54. APAC Nirsevimab Sales Market Share by Region (2021-2026)
Table 55. APAC Nirsevimab Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Nirsevimab Sales by Type (2021-2026) & (Units)
Table 57. APAC Nirsevimab Sales by Application (2021-2026) & (Units)
Table 58. Europe Nirsevimab Sales by Country (2021-2026) & (Units)
Table 59. Europe Nirsevimab Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Nirsevimab Sales by Type (2021-2026) & (Units)
Table 61. Europe Nirsevimab Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Nirsevimab Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Nirsevimab Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Nirsevimab Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Nirsevimab Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Nirsevimab
Table 67. Key Market Challenges & Risks of Nirsevimab
Table 68. Key Industry Trends of Nirsevimab
Table 69. Nirsevimab Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Nirsevimab Distributors List
Table 72. Nirsevimab Customer List
Table 73. Global Nirsevimab Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Nirsevimab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Nirsevimab Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Nirsevimab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Nirsevimab Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Nirsevimab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Nirsevimab Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Nirsevimab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Nirsevimab Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Nirsevimab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Nirsevimab Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Nirsevimab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Nirsevimab Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Nirsevimab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. AstraZeneca Basic Information, Nirsevimab Manufacturing Base, Sales Area and Its Competitors
Table 88. AstraZeneca Nirsevimab Product Portfolios and Specifications
Table 89. AstraZeneca Nirsevimab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AstraZeneca Main Business
Table 91. AstraZeneca Latest Developments
Table 92. Sanofi Basic Information, Nirsevimab Manufacturing Base, Sales Area and Its Competitors
Table 93. Sanofi Nirsevimab Product Portfolios and Specifications
Table 94. Sanofi Nirsevimab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Sanofi Main Business
Table 96. Sanofi Latest Developments
LIST OF FIGURES
Figure 1. Picture of Nirsevimab
Figure 2. Nirsevimab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nirsevimab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Nirsevimab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nirsevimab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nirsevimab Sales Market Share by Country/Region (2025)
Figure 10. Nirsevimab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50 mg (0.5 mL) / syringe
Figure 12. Product Picture of 100 mg (1.0 mL) / syringe
Figure 13. Global Nirsevimab Sales Market Share by Type in 2026
Figure 14. Global Nirsevimab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Nirsevimab Sales Market Share by Sales Channels in 2026
Figure 19. Global Nirsevimab Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture of Intramuscular Injection
Figure 21. Product Picture of Subcutaneous Injection
Figure 22. Global Nirsevimab Sales Market Share by Route of Administration in 2026
Figure 23. Global Nirsevimab Revenue Market Share by Route of Administration (2021-2026)
Figure 24. Nirsevimab Consumed in Prevention Of Respiratory Syncytial Virus Infection
Figure 25. Global Nirsevimab Market: Prevention Of Respiratory Syncytial Virus Infection (2021-2026) & (Units)
Figure 26. Nirsevimab Consumed in Reduction Of Severe Lower Respiratory Tract Disease
Figure 27. Global Nirsevimab Market: Reduction Of Severe Lower Respiratory Tract Disease (2021-2026) & (Units)
Figure 28. Nirsevimab Consumed in Protection Of Infants During Rsv Season
Figure 29. Global Nirsevimab Market: Protection Of Infants During Rsv Season (2021-2026) & (Units)
Figure 30. Nirsevimab Consumed in Others
Figure 31. Global Nirsevimab Market: Others (2021-2026) & (Units)
Figure 32. Global Nirsevimab Sale Market Share by Application (2025)
Figure 33. Global Nirsevimab Revenue Market Share by Application in 2025
Figure 34. Nirsevimab Sales by Company in 2025 (Units)
Figure 35. Global Nirsevimab Sales Market Share by Company in 2025
Figure 36. Nirsevimab Revenue by Company in 2025 ($ millions)
Figure 37. Global Nirsevimab Revenue Market Share by Company in 2025
Figure 38. Global Nirsevimab Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Nirsevimab Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Nirsevimab Sales 2021-2026 (Units)
Figure 41. Americas Nirsevimab Revenue 2021-2026 ($ millions)
Figure 42. APAC Nirsevimab Sales 2021-2026 (Units)
Figure 43. APAC Nirsevimab Revenue 2021-2026 ($ millions)
Figure 44. Europe Nirsevimab Sales 2021-2026 (Units)
Figure 45. Europe Nirsevimab Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Nirsevimab Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Nirsevimab Revenue 2021-2026 ($ millions)
Figure 48. Americas Nirsevimab Sales Market Share by Country in 2025
Figure 49. Americas Nirsevimab Revenue Market Share by Country (2021-2026)
Figure 50. Americas Nirsevimab Sales Market Share by Type (2021-2026)
Figure 51. Americas Nirsevimab Sales Market Share by Application (2021-2026)
Figure 52. United States Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Nirsevimab Sales Market Share by Region in 2025
Figure 57. APAC Nirsevimab Revenue Market Share by Region (2021-2026)
Figure 58. APAC Nirsevimab Sales Market Share by Type (2021-2026)
Figure 59. APAC Nirsevimab Sales Market Share by Application (2021-2026)
Figure 60. China Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 64. India Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Nirsevimab Sales Market Share by Country in 2025
Figure 68. Europe Nirsevimab Revenue Market Share by Country (2021-2026)
Figure 69. Europe Nirsevimab Sales Market Share by Type (2021-2026)
Figure 70. Europe Nirsevimab Sales Market Share by Application (2021-2026)
Figure 71. Germany Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 72. France Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Nirsevimab Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Nirsevimab Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Nirsevimab Sales Market Share by Application (2021-2026)
Figure 79. Egypt Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Nirsevimab in 2026
Figure 85. Manufacturing Process Analysis of Nirsevimab
Figure 86. Industry Chain Structure of Nirsevimab
Figure 87. Channels of Distribution
Figure 88. Global Nirsevimab Sales Market Forecast by Region (2027-2032)
Figure 89. Global Nirsevimab Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Nirsevimab Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Nirsevimab Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Nirsevimab Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Nirsevimab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Nirsevimab
Figure 2. Nirsevimab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nirsevimab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Nirsevimab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Nirsevimab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Nirsevimab Sales Market Share by Country/Region (2025)
Figure 10. Nirsevimab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 50 mg (0.5 mL) / syringe
Figure 12. Product Picture of 100 mg (1.0 mL) / syringe
Figure 13. Global Nirsevimab Sales Market Share by Type in 2026
Figure 14. Global Nirsevimab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Retail
Figure 17. Product Picture of Online
Figure 18. Global Nirsevimab Sales Market Share by Sales Channels in 2026
Figure 19. Global Nirsevimab Revenue Market Share by Sales Channels (2021-2026)
Figure 20. Product Picture of Intramuscular Injection
Figure 21. Product Picture of Subcutaneous Injection
Figure 22. Global Nirsevimab Sales Market Share by Route of Administration in 2026
Figure 23. Global Nirsevimab Revenue Market Share by Route of Administration (2021-2026)
Figure 24. Nirsevimab Consumed in Prevention Of Respiratory Syncytial Virus Infection
Figure 25. Global Nirsevimab Market: Prevention Of Respiratory Syncytial Virus Infection (2021-2026) & (Units)
Figure 26. Nirsevimab Consumed in Reduction Of Severe Lower Respiratory Tract Disease
Figure 27. Global Nirsevimab Market: Reduction Of Severe Lower Respiratory Tract Disease (2021-2026) & (Units)
Figure 28. Nirsevimab Consumed in Protection Of Infants During Rsv Season
Figure 29. Global Nirsevimab Market: Protection Of Infants During Rsv Season (2021-2026) & (Units)
Figure 30. Nirsevimab Consumed in Others
Figure 31. Global Nirsevimab Market: Others (2021-2026) & (Units)
Figure 32. Global Nirsevimab Sale Market Share by Application (2025)
Figure 33. Global Nirsevimab Revenue Market Share by Application in 2025
Figure 34. Nirsevimab Sales by Company in 2025 (Units)
Figure 35. Global Nirsevimab Sales Market Share by Company in 2025
Figure 36. Nirsevimab Revenue by Company in 2025 ($ millions)
Figure 37. Global Nirsevimab Revenue Market Share by Company in 2025
Figure 38. Global Nirsevimab Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Nirsevimab Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Nirsevimab Sales 2021-2026 (Units)
Figure 41. Americas Nirsevimab Revenue 2021-2026 ($ millions)
Figure 42. APAC Nirsevimab Sales 2021-2026 (Units)
Figure 43. APAC Nirsevimab Revenue 2021-2026 ($ millions)
Figure 44. Europe Nirsevimab Sales 2021-2026 (Units)
Figure 45. Europe Nirsevimab Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Nirsevimab Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Nirsevimab Revenue 2021-2026 ($ millions)
Figure 48. Americas Nirsevimab Sales Market Share by Country in 2025
Figure 49. Americas Nirsevimab Revenue Market Share by Country (2021-2026)
Figure 50. Americas Nirsevimab Sales Market Share by Type (2021-2026)
Figure 51. Americas Nirsevimab Sales Market Share by Application (2021-2026)
Figure 52. United States Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Nirsevimab Sales Market Share by Region in 2025
Figure 57. APAC Nirsevimab Revenue Market Share by Region (2021-2026)
Figure 58. APAC Nirsevimab Sales Market Share by Type (2021-2026)
Figure 59. APAC Nirsevimab Sales Market Share by Application (2021-2026)
Figure 60. China Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 64. India Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Nirsevimab Sales Market Share by Country in 2025
Figure 68. Europe Nirsevimab Revenue Market Share by Country (2021-2026)
Figure 69. Europe Nirsevimab Sales Market Share by Type (2021-2026)
Figure 70. Europe Nirsevimab Sales Market Share by Application (2021-2026)
Figure 71. Germany Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 72. France Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Nirsevimab Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Nirsevimab Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Nirsevimab Sales Market Share by Application (2021-2026)
Figure 79. Egypt Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Nirsevimab Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Nirsevimab in 2026
Figure 85. Manufacturing Process Analysis of Nirsevimab
Figure 86. Industry Chain Structure of Nirsevimab
Figure 87. Channels of Distribution
Figure 88. Global Nirsevimab Sales Market Forecast by Region (2027-2032)
Figure 89. Global Nirsevimab Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Nirsevimab Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Nirsevimab Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Nirsevimab Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Nirsevimab Revenue Market Share Forecast by Application (2027-2032)
